. Asia Contrary to how the Asian graph reflects lower earnings, busi- ness sentiments are starting to im- prove. EBITDA and ROCE were weak for the quarter and LTM due to de-consolidation on India PET
value as at 30 September 2019, an indicative purchase price of IDR 1,498 per share and an indicative transaction value of IDR 37,430,974 million (approximately US$ 2,674 million or THB 81,017 million2
required by the relevant Indonesian regulations. Therefore, the indicative transaction value based on the financial statements as at 30 September 2019 may range between IDR 37,430,974 million and IDR
economy, we are expecting improvement in the sentiments from Q4 onwards. • Total assets As of 30 June 2019, the Company has total assets amounting to THB 16,997 million which decreased from the year ended
Anti- Dumping and Countervailing of Foreign Products Act, we are expecting improvement in the sentiments from Q4 onwards. Performance Revenue from sale and cost of sale Total revenue from sales of the
. Financial assistance to Medical Vision Company Limited 3. Indicative terms of warrants to purchase ordinary shares in the Company (FVC-W3) 4. Form of Capital Increase Report (Form 53-4) Filter Vision Public
(specify the name of the fund) is not indicative of future performance.” The warning and the fund’s past performance shall be on the same page; (b) a statement specifying that the measurement of fund
other information in the advertisement, and shall have the following statements: (a) a warning stating that “the past performance of (specify the name of the fund) is not indicative of future performance
performance of (specify the name of the fund) is not indicative of future performance.” The warning and the fund’s past performance shall be on the same page; (b) a statement specifying that the measurement of